CHLOE BLANKENHORN: Open Payments
NPI 1922327121 · HOMEWOOD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 22 payments from 5 companies in 2025. Trend: 2023 $148 · 2024 $7,535 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 17 | $164 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $46 |
| Vantive US Healthcare LLC | 1 | $38 |
| Calliditas Therapeutics US Inc. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
Products named: VELPHORO, Tryvio, Renal - PD, TARPEYO, FARXIGA, OPTIFLUX.
Industry payments across AL — which companies pay providers there.
